FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2334100723> ?p ?o ?g. }

• W2334100723 endingPage "S262" @default.
• W2334100723 startingPage "S262" @default.
• W2334100723 abstract "The aim of this study was to evaluate the safety, tolerability, and pharmacokinetic parameters of up to 15 dose levels of ONO-4232, a selective agonist for the EP4 subtype of the prostaglandin E2 receptor, with a dual left ventricular lusitropic and venodilatory action, in healthy, adult, male and female volunteers.In this randomized, single-center, double-blind, placebo-controlled, single-dose, sequential-group escalation, first in human study, ONO-4232 (0.001, 0.003, 0.01, 0.02, 0.04, 0.08, 0.12, 0.15, 0.18, or 0.27 ng/kg/min) or placebo was administered as a continuous intravenous infusion over 3 hours. Safety, tolerability, and pharmacokinetic data were collected during dosing and over a period of 3 days (Day –1 to Day 2), and at the follow-up visit (Day 7 [±2 days]).Fifty-seven subjects received ONO-4232 and 19 subjects received placebo. Ten of the planned 15 cohorts (dose range, 0.001–0.27 ng/kg/min) were conducted. A total of 34 treatment-emergent adverse events (TEAEs) were reported in 23 subjects. Overall, the majority of TEAEs were mild. No serious TEAEs or deaths were reported and no subjects discontinued due to adverse events. The most frequently reported TEAE was infusion site erythema. A decrease in systolic blood pressure from baseline occurred for ONO-4232 subjects compared with placebo that was statistically significant for the 0.08 ng/kg/min dose, and a dose-dependent increase in heart rate starting at 0.04 ng/kg/min and achieving statistical significance compared with placebo at 0.15 ng/kg/min and above. More orthostatic events occurred in the higher-dose groups and the dose escalation was terminated due to increasing occurrences of orthostatic hypotension/intolerance. Plasma concentrations of ONO-4232 reached steady state approximately 2 hours after the start of infusion and then declined rapidly after the end of infusion, and systemic exposure appeared to increase in a dose-proportional manner. Approximately 30% of the administered dose of ONO-4232 was excreted in the urine.In healthy adults ONO-4232 was generally well tolerated in the dose range of 0.001 to 0.27 ng/kg/min. There were dose-related changes in systolic blood pressure and heart rate. Infusion site erythema, which was likely associated with a venodilatory effect and possible evidence for the pharmacologic effects of ONO-4232, occurred increasingly with increasing dose. Pharmacokinetic parameters appeared to be dose-proportional. The study results support further evaluation of the cardiovascular effects of this first-in-class selective left ventricular lusitropic and venodilatory drug in patients with acutely decompensated heart failure." @default.
• W2334100723 created "2016-06-24" @default.
• W2334100723 creator A5002807505 @default.
• W2334100723 creator A5020295735 @default.
• W2334100723 creator A5027777637 @default.
• W2334100723 creator A5032720710 @default.
• W2334100723 creator A5088023341 @default.
• W2334100723 date "2012-10-01" @default.
• W2334100723 modified "2023-10-14" @default.
• W2334100723 title "P.2.c.021 Levomilnacipran in the treatment of major depressive disorder: an analysis of efficacy and safety data from two phase III studies" @default.
• W2334100723 doi "https://doi.org/10.1016/s0924-977x(12)70394-2" @default.
• W2334100723 hasPublicationYear "2012" @default.
• W2334100723 type Work @default.
• W2334100723 sameAs 2334100723 @default.
• W2334100723 citedByCount "2" @default.
• W2334100723 countsByYear W23341007232013 @default.
• W2334100723 countsByYear W23341007232014 @default.
• W2334100723 crossrefType "journal-article" @default.
• W2334100723 hasAuthorship W2334100723A5002807505 @default.
• W2334100723 hasAuthorship W2334100723A5020295735 @default.
• W2334100723 hasAuthorship W2334100723A5027777637 @default.
• W2334100723 hasAuthorship W2334100723A5032720710 @default.
• W2334100723 hasAuthorship W2334100723A5088023341 @default.
• W2334100723 hasConcept C112705442 @default.
• W2334100723 hasConcept C126322002 @default.
• W2334100723 hasConcept C142724271 @default.
• W2334100723 hasConcept C197934379 @default.
• W2334100723 hasConcept C204787440 @default.
• W2334100723 hasConcept C27081682 @default.
• W2334100723 hasConcept C2777288759 @default.
• W2334100723 hasConcept C2778375690 @default.
• W2334100723 hasConcept C42219234 @default.
• W2334100723 hasConcept C71924100 @default.
• W2334100723 hasConcept C84393581 @default.
• W2334100723 hasConceptScore W2334100723C112705442 @default.
• W2334100723 hasConceptScore W2334100723C126322002 @default.
• W2334100723 hasConceptScore W2334100723C142724271 @default.
• W2334100723 hasConceptScore W2334100723C197934379 @default.
• W2334100723 hasConceptScore W2334100723C204787440 @default.
• W2334100723 hasConceptScore W2334100723C27081682 @default.
• W2334100723 hasConceptScore W2334100723C2777288759 @default.
• W2334100723 hasConceptScore W2334100723C2778375690 @default.
• W2334100723 hasConceptScore W2334100723C42219234 @default.
• W2334100723 hasConceptScore W2334100723C71924100 @default.
• W2334100723 hasConceptScore W2334100723C84393581 @default.
• W2334100723 hasLocation W23341007231 @default.
• W2334100723 hasOpenAccess W2334100723 @default.
• W2334100723 hasPrimaryLocation W23341007231 @default.
• W2334100723 hasRelatedWork W2003042623 @default.
• W2334100723 hasRelatedWork W2037651778 @default.
• W2334100723 hasRelatedWork W2068849886 @default.
• W2334100723 hasRelatedWork W2328878243 @default.
• W2334100723 hasRelatedWork W2329478898 @default.
• W2334100723 hasRelatedWork W3087516196 @default.
• W2334100723 hasRelatedWork W3197824728 @default.
• W2334100723 hasRelatedWork W3207313530 @default.
• W2334100723 hasRelatedWork W4200597295 @default.
• W2334100723 hasRelatedWork W1962564742 @default.
• W2334100723 hasVolume "22" @default.
• W2334100723 isParatext "false" @default.
• W2334100723 isRetracted "false" @default.
• W2334100723 magId "2334100723" @default.
• W2334100723 workType "article" @default.